NPI registry status
Active
2026 NPPES data Medical Oncology Physician NPI 1063875227 M.D.
Verify on CMS → Michael Lunski, M.D.
Medical Oncology Physician in Saint Joseph, Missouri.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 3,815 in Medical Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 268 beneficiaries · Medical Oncology Physician avg: 689
MIPS score
76.9/100
▼ 6 pts below national avg 83.1 · Above neutral
Industry payments
$1.5K
79 payments · CMS Open Payments (Sunshine Act)
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Michael Lunski, M.D. reported a CMS MIPS final score of 76.9/100 - below the 83.1 national average - and filed 1,545 Medicare Part D claims in 2023.
- 76.9/100
- MIPS score · -6 vs avg
- 2K
- Part D claims, 2023
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Michael Lunski, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
77 21st percentile higher than 21% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Michael Lunski, M.D. sits
This provider among medical oncology physician peers
Across the 1,527 medical oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Michael Lunski, M.D. writes more Part D claims than 87% of them and scores higher on MIPS quality than 23% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one medical oncology physician peer from a representative sample of 60; the gold marker is Michael Lunski, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Michael Lunski, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Michael Lunski, M.D.?
Below national averagePrimary specialty
Medical Oncology Physician
Medicare Part D claims
1,545 124% vs specialty avg
MIPS final score
76.9/100 6.2 pts vs avg
Specialty distribution in Missouri
How Medical Oncology Physician compares to other specialties among Missouri providers
Medicare quality performance, MIPS
Michael Lunski, M.D.'s 2023 MIPS final score plotted against the Medical Oncology Physician national average
- MIPS Final Score
- 76.9/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Medical Oncology Physician) - 76.9/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Michael Lunski, M.D. appears in the CMS NPPES registry as a Medical Oncology Physician provider holding M.D. credentials at 902 N RIVERSIDE RD STE 200, Saint Joseph, MO, 64507, with a listed phone of (816) 271-1301. NPI 1063875227 was issued on 04/04/2016.
Medicare Part D records for calendar year 2023 show 1,545 prescription claims written by this provider, covering 268 Medicare beneficiaries and totaling roughly $2.7 million in drug spend, with an opioid prescribing rate of 9.0%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 76.9/100 for the 2023 performance year (Quality 66.5, Cost 56.5), compared with the national average of 83.1.
Medical Oncology Physician is a narrow specialty nationwide, with 3,815 enrolled providers across 53 states and an average of 689 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1063875227 |
|---|---|
| Specialty | Medical Oncology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 04/04/2016 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
76.9217
Final Score
Avg: 83.1
66.5332
Quality
56.5392
Cost
100
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Michael Lunski, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Heartland Regional Medical Center
St Joseph, MO
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Michael Lunski, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$1.5K
Largest payer
AstraZeneca Pharmaceuticals LP
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
1,545
Total Claims
$2.7M
Total Drug Cost
268
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 2,122
- Total Day Supply
- 55,436
- Generic Drug Cost
- $278K
- Opioid Claims
- 139 (9.0% rate)
- Antibiotic Claims
- 38
Patient Demographics
- Average Patient Age
- 72.7 years
- Avg HCC Risk Score
- 2.13
- Gender Split
- 65% female / 35% male
- Age Distribution
- <65: 37, 65-74: 117, 75-84: 88, 85+: 26
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Michael Lunski, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Anastrozole
Anastrozole
231 claims
- Ondansetron Hcl 70
Ondansetron Hcl
70 claims
- Hydroxyurea 60
Hydroxyurea
60 claims
- Levothyroxine Sodium 52
Levothyroxine Sodium
52 claims
- Gabapentin 50
Gabapentin
50 claims
- Potassium Chloride 49
Potassium Chloride
49 claims
- Prednisone 42
Prednisone
42 claims
- Letrozole 40
Letrozole
40 claims
| Drug | Claims |
|---|---|
| Anastrozole | 231 |
| Ondansetron Hcl | 70 |
| Hydroxyurea | 60 |
| Levothyroxine Sodium | 52 |
| Gabapentin | 50 |
| Potassium Chloride | 49 |
| Prednisone | 42 |
| Letrozole | 40 |
| Oxycodone Hcl | 40 |
| Dexamethasone | 38 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Medical Oncology Physician Overview
How Michael Lunski, M.D. fits within the Medical Oncology Physician landscape nationally.
3,815
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
689
Avg Claims per Provider
Michael Lunski, M.D.'s 1,545 claims are above the specialty average of 689.
Nearby Medical Oncology Physician Providers in Missouri
Other clinicians with the same primary specialty enrolled in Missouri, drawn from the same CMS NPPES roster as Lunski.
Dr. Elliot Abbey
MD
Chesterfield, MO
Dr. Camille Abboud
MD
Saint Louis, MO
Dr. Rony Abou-Jawde
MD
St Joseph, MO
Dr. Foluso Ademuyiwa
MD
Saint Louis, MO
Dr. Douglas Adkins
MD
Saint Louis, MO
Compare Medical Oncology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Missouri medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Medical Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Missouri
Frequently Asked Questions
What is Michael Lunski, M.D.'s specialty? ▼
Michael Lunski, M.D. specializes in Medical Oncology Physician and practices in Saint Joseph, Missouri. Credentials: M.D..
How much does Michael Lunski, M.D. prescribe under Medicare Part D? ▼
In 2023, Michael Lunski, M.D. wrote 1,545 Medicare Part D claims totaling $2.7M in drug costs for 268 beneficiaries.
What is Michael Lunski, M.D.'s Medicare quality score? ▼
Michael Lunski, M.D. has a CMS MIPS Final Score of 76.9/100 (Quality: 66.5, Cost: 56.5). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Michael Lunski, M.D. located? ▼
Michael Lunski, M.D. is located at 902 N RIVERSIDE RD STE 200, Saint Joseph, MO, 64507. Phone: (816) 271-1301.
What is Michael Lunski, M.D.'s NPI number? ▼
Michael Lunski, M.D.'s National Provider Identifier (NPI) is 1063875227, issued on 04/04/2016.
Does Michael Lunski, M.D. prescribe opioids? ▼
Yes, Michael Lunski, M.D. had 139 opioid claims in 2023 with an opioid prescribing rate of 9.0%.
How many Medical Oncology Physician providers are there in the US? ▼
There are 3,815 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 689 Medicare Part D claims per year.
What drugs does Michael Lunski, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Michael Lunski, M.D.'s most frequently prescribed drugs include Anastrozole, Ondansetron Hcl, Hydroxyurea. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Michael Lunski, M.D. accept Medicare? ▼
Michael Lunski, M.D. appears in CMS Medicare data with 1,545 Part D claims and 268 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Michael Lunski, M.D.'s credentials? ▼
Michael Lunski, M.D.'s NPI is 1063875227 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.